X0306 4 2018-01-02 0001588972 Recro Pharma, Inc. REPH 0001297318 Mattila Jyrki C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Executive VP, Business Dev. Common Stock 2018-01-02 4 A 0 11500 0 A 11500 D Employee Stock Option (right to buy) 9.04 2018-01-02 4 A 0 23000 0 A 2028-01-02 Common Stock 23000 23000 D All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. /s/ Ryan D. Lake, Attorney-in-fact 2018-01-04